HBDI
The Herrmann Brain Dominance Instrument (HBDI) is a 116-question, highly validated diagnostic survey that measures thinking preferences across four integrated systems, metaphorically mapped onto the brain's quadrants. Developed by Ned Herrmann during his tenure as management education leader at General Electric, the HBDI was created to assess how thought processes and thinking preferences impact management and leadership development. Unlike other assessments that focus on behavior or personality, the HBDI provides insight into an individual's thinking preferences, influencing their approach to problem-solving and decision-making. It does not measure ability, aptitude, or capabilities, nor does it assess activity in specific localized areas of the brain. The HBDI has been utilized by over 4 million people in more than 60 countries and is available in 16 languages. It serves as a foundational tool for organizations aiming to harness cognitive diversity.
Learn more
HappyNeuron
HappyNeuron is a digital cognitive therapy tool designed to assist clinicians in providing cognitive rehabilitation, remediation, and stimulation. The platform offers a growing collection of 45 adaptable exercises targeting various cognitive functions, including executive function, memory, visual-spatial abilities, language, attention, processing speed, and auditory processing. These exercises are customizable to appropriately challenge each patient's unique needs. The platform also provides printable worksheets, allowing clinicians to expand their therapy tools with science-based materials. Additionally, HappyNeuron Pro offers automatic progress tracking and reporting, enabling clinicians to monitor patient improvements efficiently. The platform supports multiple languages, facilitating treatment of patients in their native language. Clinicians can also assign home exercises to patients, increasing the duration and intensity of therapy, which may enhance cognitive health outcomes.
Learn more
MoCA Cognition
The Montreal Cognitive Assessment (MoCA) is a brief, 30-question test that helps healthcare professionals detect cognitive impairments very early on, allowing for faster diagnosis and patient care. MoCA empowers healthcare professionals and researchers to detect cognitive impairment related to conditions such as Alzheimer's disease, Parkinson's disease, Huntington's disease, Lewy Body Dementia, VCI/Stroke, frontotemporal dementia, brain metastasis, ALS, sleep behavior disorder, brain tumors, multiple sclerosis, head trauma, depression, schizophrenia, heart failure, substance abuse, HIV, COVID, and more. MoCA is regularly used by nurses, primary care and specialty physicians, occupational therapists, speech-language pathologists, psychologists, researchers, and other clinicians. It quickly and accurately assesses short-term memory, visuospatial abilities, executive functions, attention, concentration and working memory, language, and orientation to time and place.
Learn more
CANTAB
Originally developed at the University of Cambridge, the Cambridge Neuropsychological Test Automated Battery (CANTAB) includes highly sensitive, precise and objective measures of cognitive function, correlated to neural networks. CANTAB tests have demonstrated sensitivity to detecting changes in neuropsychological performance and include tests of working memory, learning and executive function; visual, verbal and episodic memory; attention, information processing and reaction time; social and emotion recognition, decision making and response control. Cognitive assessments are invaluable tools for understanding the role of specific brain functions across a range of disorders and syndromes; giving insight into underlying causes, identifying ways to detect the earliest symptoms and evaluating the effects of interventions designed to improve brain health.
Learn more
